Yesterday, the Chairman & CEO of NantKwest (NK), Shiong Patrick Soon, bought shares of NK for $35M.
Following this transaction Shiong Patrick Soon’s holding in the company was increased by 37.59% to a total of $88.75 million.
See today’s analyst top recommended stocks >>
Currently, NantKwest has an average volume of 342.2K.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
NantKwest, Inc. engages in the development of immunotherapies with a focus on harnessing the power of the innate immune system. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The firm operates through the following geographical segments: United States; Europe; and Other Non-U.S. The company was founded by Gary N.
